RxDoctor Payments Data

Percy Boateng, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · New York, NYNPI 1861437550

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 83.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $14,245 and has fallen 97.6% since, to $341 in 2025.

$21,524in general payments, 2019–2025

Across 76 payments — averaging $283.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$18K
  • Abbott$1K
  • Artivion, Inc.$1K
  • Enablecv Inc.$441
  • Medtronic$361
  • Atricure, Inc.$216
  • plus $136 from 2 others
$135,846in research payments, 2019–2025

Across 20 payments — averaging $6792.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$136K

What the payments were for

  • Consulting fees$8,96542%
  • Speaking & faculty fees$5002%
  • Travel & lodging$7,19733%
  • Food & beverage$4,86223%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences45$18,063
Abbott12$1,219
Artivion, Inc.3$1,088
Enablecv Inc.2$441
Medtronic(2 entities)7$361
Atricure, Inc.5$216
Baxter Healthcare1$104
Lemaitre Vascular, Inc.1$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,524 in reported general payments places this provider in the 80th percentile of 383 thoracic surgery (cardiothoracic vascular surgery) providers in New York.

See all thoracic surgery (cardiothoracic vascular surgery) providers in New York

Medicare billing

Part B allowed, 2024
$176,992
Medicare patients
84
Services billed
233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →